Bioengineered Protein Drugs Market, Global Outlook and Forecast 2022-2028

April 2022 | 71 pages | ID: B4CCCFBB2842EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Bioengineered Protein Drugs in global, including the following market information:

Global Bioengineered Protein Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Bioengineered Protein Drugs Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Bioengineered Protein Drugs companies in 2021 (%)

The global Bioengineered Protein Drugs market was valued at 86200 million in 2021 and is projected to reach US$ 112310 million by 2028, at a CAGR of 3.9% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Monoclonal Antibodies Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Bioengineered Protein Drugs include Dr.Reddy’s, Eli Lilly, Merck, Reliance Life Sciences, Panacea Biotech, Novartis, Fresenius, Sanofi and ProBioGen, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Bioengineered Protein Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Bioengineered Protein Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Bioengineered Protein Drugs Market Segment Percentages, by Type, 2021 (%)

• Monoclonal Antibodies
• Therapeutic Proteins
• Vaccines

Global Bioengineered Protein Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Bioengineered Protein Drugs Market Segment Percentages, by Application, 2021 (%)

• Cancer
• Diabetes
• Autoimmune Disorder
• Infectious Disease
• Neurodegenerative
• Others

Global Bioengineered Protein Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Bioengineered Protein Drugs Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Bioengineered Protein Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Bioengineered Protein Drugs revenues share in global market, 2021 (%)

Key companies Bioengineered Protein Drugs sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Bioengineered Protein Drugs sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Dr.Reddy’s
• Eli Lilly
• Merck
• Reliance Life Sciences
• Panacea Biotech
• Novartis
• Fresenius
• Sanofi
• ProBioGen
• GlaxoSmithKline
• Roche
• Amoytop Biotech
• Shanghai United Cell Biotechnology
• Hualan Bio

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Bioengineered Protein Drugs Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Bioengineered Protein Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL BIOENGINEERED PROTEIN DRUGS OVERALL MARKET SIZE

2.1 Global Bioengineered Protein Drugs Market Size: 2021 VS 2028
2.2 Global Bioengineered Protein Drugs Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Bioengineered Protein Drugs Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Bioengineered Protein Drugs Players in Global Market
3.2 Top Global Bioengineered Protein Drugs Companies Ranked by Revenue
3.3 Global Bioengineered Protein Drugs Revenue by Companies
3.4 Global Bioengineered Protein Drugs Sales by Companies
3.5 Global Bioengineered Protein Drugs Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Bioengineered Protein Drugs Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Bioengineered Protein Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Bioengineered Protein Drugs Players in Global Market
  3.8.1 List of Global Tier 1 Bioengineered Protein Drugs Companies
  3.8.2 List of Global Tier 2 and Tier 3 Bioengineered Protein Drugs Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Bioengineered Protein Drugs Market Size Markets, 2021 & 2028
  4.1.2 Monoclonal Antibodies
  4.1.3 Therapeutic Proteins
  4.1.4 Vaccines
4.2 By Type - Global Bioengineered Protein Drugs Revenue & Forecasts
  4.2.1 By Type - Global Bioengineered Protein Drugs Revenue, 2017-2022
  4.2.2 By Type - Global Bioengineered Protein Drugs Revenue, 2023-2028
  4.2.3 By Type - Global Bioengineered Protein Drugs Revenue Market Share, 2017-2028
4.3 By Type - Global Bioengineered Protein Drugs Sales & Forecasts
  4.3.1 By Type - Global Bioengineered Protein Drugs Sales, 2017-2022
  4.3.2 By Type - Global Bioengineered Protein Drugs Sales, 2023-2028
  4.3.3 By Type - Global Bioengineered Protein Drugs Sales Market Share, 2017-2028
4.4 By Type - Global Bioengineered Protein Drugs Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Bioengineered Protein Drugs Market Size, 2021 & 2028
  5.1.2 Cancer
  5.1.3 Diabetes
  5.1.4 Autoimmune Disorder
  5.1.5 Infectious Disease
  5.1.6 Neurodegenerative
  5.1.7 Others
5.2 By Application - Global Bioengineered Protein Drugs Revenue & Forecasts
  5.2.1 By Application - Global Bioengineered Protein Drugs Revenue, 2017-2022
  5.2.2 By Application - Global Bioengineered Protein Drugs Revenue, 2023-2028
  5.2.3 By Application - Global Bioengineered Protein Drugs Revenue Market Share, 2017-2028
5.3 By Application - Global Bioengineered Protein Drugs Sales & Forecasts
  5.3.1 By Application - Global Bioengineered Protein Drugs Sales, 2017-2022
  5.3.2 By Application - Global Bioengineered Protein Drugs Sales, 2023-2028
  5.3.3 By Application - Global Bioengineered Protein Drugs Sales Market Share, 2017-2028
5.4 By Application - Global Bioengineered Protein Drugs Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Bioengineered Protein Drugs Market Size, 2021 & 2028
6.2 By Region - Global Bioengineered Protein Drugs Revenue & Forecasts
  6.2.1 By Region - Global Bioengineered Protein Drugs Revenue, 2017-2022
  6.2.2 By Region - Global Bioengineered Protein Drugs Revenue, 2023-2028
  6.2.3 By Region - Global Bioengineered Protein Drugs Revenue Market Share, 2017-2028
6.3 By Region - Global Bioengineered Protein Drugs Sales & Forecasts
  6.3.1 By Region - Global Bioengineered Protein Drugs Sales, 2017-2022
  6.3.2 By Region - Global Bioengineered Protein Drugs Sales, 2023-2028
  6.3.3 By Region - Global Bioengineered Protein Drugs Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Bioengineered Protein Drugs Revenue, 2017-2028
  6.4.2 By Country - North America Bioengineered Protein Drugs Sales, 2017-2028
  6.4.3 US Bioengineered Protein Drugs Market Size, 2017-2028
  6.4.4 Canada Bioengineered Protein Drugs Market Size, 2017-2028
  6.4.5 Mexico Bioengineered Protein Drugs Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Bioengineered Protein Drugs Revenue, 2017-2028
  6.5.2 By Country - Europe Bioengineered Protein Drugs Sales, 2017-2028
  6.5.3 Germany Bioengineered Protein Drugs Market Size, 2017-2028
  6.5.4 France Bioengineered Protein Drugs Market Size, 2017-2028
  6.5.5 U.K. Bioengineered Protein Drugs Market Size, 2017-2028
  6.5.6 Italy Bioengineered Protein Drugs Market Size, 2017-2028
  6.5.7 Russia Bioengineered Protein Drugs Market Size, 2017-2028
  6.5.8 Nordic Countries Bioengineered Protein Drugs Market Size, 2017-2028
  6.5.9 Benelux Bioengineered Protein Drugs Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Bioengineered Protein Drugs Revenue, 2017-2028
  6.6.2 By Region - Asia Bioengineered Protein Drugs Sales, 2017-2028
  6.6.3 China Bioengineered Protein Drugs Market Size, 2017-2028
  6.6.4 Japan Bioengineered Protein Drugs Market Size, 2017-2028
  6.6.5 South Korea Bioengineered Protein Drugs Market Size, 2017-2028
  6.6.6 Southeast Asia Bioengineered Protein Drugs Market Size, 2017-2028
  6.6.7 India Bioengineered Protein Drugs Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Bioengineered Protein Drugs Revenue, 2017-2028
  6.7.2 By Country - South America Bioengineered Protein Drugs Sales, 2017-2028
  6.7.3 Brazil Bioengineered Protein Drugs Market Size, 2017-2028
  6.7.4 Argentina Bioengineered Protein Drugs Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Bioengineered Protein Drugs Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Bioengineered Protein Drugs Sales, 2017-2028
  6.8.3 Turkey Bioengineered Protein Drugs Market Size, 2017-2028
  6.8.4 Israel Bioengineered Protein Drugs Market Size, 2017-2028
  6.8.5 Saudi Arabia Bioengineered Protein Drugs Market Size, 2017-2028
  6.8.6 UAE Bioengineered Protein Drugs Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Dr.Reddy’s
  7.1.1 Dr.Reddy’s Corporate Summary
  7.1.2 Dr.Reddy’s Business Overview
  7.1.3 Dr.Reddy’s Bioengineered Protein Drugs Major Product Offerings
  7.1.4 Dr.Reddy’s Bioengineered Protein Drugs Sales and Revenue in Global (2017-2022)
  7.1.5 Dr.Reddy’s Key News
7.2 Eli Lilly
  7.2.1 Eli Lilly Corporate Summary
  7.2.2 Eli Lilly Business Overview
  7.2.3 Eli Lilly Bioengineered Protein Drugs Major Product Offerings
  7.2.4 Eli Lilly Bioengineered Protein Drugs Sales and Revenue in Global (2017-2022)
  7.2.5 Eli Lilly Key News
7.3 Merck
  7.3.1 Merck Corporate Summary
  7.3.2 Merck Business Overview
  7.3.3 Merck Bioengineered Protein Drugs Major Product Offerings
  7.3.4 Merck Bioengineered Protein Drugs Sales and Revenue in Global (2017-2022)
  7.3.5 Merck Key News
7.4 Reliance Life Sciences
  7.4.1 Reliance Life Sciences Corporate Summary
  7.4.2 Reliance Life Sciences Business Overview
  7.4.3 Reliance Life Sciences Bioengineered Protein Drugs Major Product Offerings
  7.4.4 Reliance Life Sciences Bioengineered Protein Drugs Sales and Revenue in Global (2017-2022)
  7.4.5 Reliance Life Sciences Key News
7.5 Panacea Biotech
  7.5.1 Panacea Biotech Corporate Summary
  7.5.2 Panacea Biotech Business Overview
  7.5.3 Panacea Biotech Bioengineered Protein Drugs Major Product Offerings
  7.5.4 Panacea Biotech Bioengineered Protein Drugs Sales and Revenue in Global (2017-2022)
  7.5.5 Panacea Biotech Key News
7.6 Novartis
  7.6.1 Novartis Corporate Summary
  7.6.2 Novartis Business Overview
  7.6.3 Novartis Bioengineered Protein Drugs Major Product Offerings
  7.6.4 Novartis Bioengineered Protein Drugs Sales and Revenue in Global (2017-2022)
  7.6.5 Novartis Key News
7.7 Fresenius
  7.7.1 Fresenius Corporate Summary
  7.7.2 Fresenius Business Overview
  7.7.3 Fresenius Bioengineered Protein Drugs Major Product Offerings
  7.7.4 Fresenius Bioengineered Protein Drugs Sales and Revenue in Global (2017-2022)
  7.7.5 Fresenius Key News
7.8 Sanofi
  7.8.1 Sanofi Corporate Summary
  7.8.2 Sanofi Business Overview
  7.8.3 Sanofi Bioengineered Protein Drugs Major Product Offerings
  7.8.4 Sanofi Bioengineered Protein Drugs Sales and Revenue in Global (2017-2022)
  7.8.5 Sanofi Key News
7.9 ProBioGen
  7.9.1 ProBioGen Corporate Summary
  7.9.2 ProBioGen Business Overview
  7.9.3 ProBioGen Bioengineered Protein Drugs Major Product Offerings
  7.9.4 ProBioGen Bioengineered Protein Drugs Sales and Revenue in Global (2017-2022)
  7.9.5 ProBioGen Key News
7.10 GlaxoSmithKline
  7.10.1 GlaxoSmithKline Corporate Summary
  7.10.2 GlaxoSmithKline Business Overview
  7.10.3 GlaxoSmithKline Bioengineered Protein Drugs Major Product Offerings
  7.10.4 GlaxoSmithKline Bioengineered Protein Drugs Sales and Revenue in Global (2017-2022)
  7.10.5 GlaxoSmithKline Key News
7.11 Roche
  7.11.1 Roche Corporate Summary
  7.11.2 Roche Bioengineered Protein Drugs Business Overview
  7.11.3 Roche Bioengineered Protein Drugs Major Product Offerings
  7.11.4 Roche Bioengineered Protein Drugs Sales and Revenue in Global (2017-2022)
  7.11.5 Roche Key News
7.12 Amoytop Biotech
  7.12.1 Amoytop Biotech Corporate Summary
  7.12.2 Amoytop Biotech Bioengineered Protein Drugs Business Overview
  7.12.3 Amoytop Biotech Bioengineered Protein Drugs Major Product Offerings
  7.12.4 Amoytop Biotech Bioengineered Protein Drugs Sales and Revenue in Global (2017-2022)
  7.12.5 Amoytop Biotech Key News
7.13 Shanghai United Cell Biotechnology
  7.13.1 Shanghai United Cell Biotechnology Corporate Summary
  7.13.2 Shanghai United Cell Biotechnology Bioengineered Protein Drugs Business Overview
  7.13.3 Shanghai United Cell Biotechnology Bioengineered Protein Drugs Major Product Offerings
  7.13.4 Shanghai United Cell Biotechnology Bioengineered Protein Drugs Sales and Revenue in Global (2017-2022)
  7.13.5 Shanghai United Cell Biotechnology Key News
7.14 Hualan Bio
  7.14.1 Hualan Bio Corporate Summary
  7.14.2 Hualan Bio Business Overview
  7.14.3 Hualan Bio Bioengineered Protein Drugs Major Product Offerings
  7.14.4 Hualan Bio Bioengineered Protein Drugs Sales and Revenue in Global (2017-2022)
  7.14.5 Hualan Bio Key News

8 GLOBAL BIOENGINEERED PROTEIN DRUGS PRODUCTION CAPACITY, ANALYSIS

8.1 Global Bioengineered Protein Drugs Production Capacity, 2017-2028
8.2 Bioengineered Protein Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Bioengineered Protein Drugs Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 BIOENGINEERED PROTEIN DRUGS SUPPLY CHAIN ANALYSIS

10.1 Bioengineered Protein Drugs Industry Value Chain
10.2 Bioengineered Protein Drugs Upstream Market
10.3 Bioengineered Protein Drugs Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Bioengineered Protein Drugs Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Bioengineered Protein Drugs in Global Market
Table 2. Top Bioengineered Protein Drugs Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Bioengineered Protein Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Bioengineered Protein Drugs Revenue Share by Companies, 2017-2022
Table 5. Global Bioengineered Protein Drugs Sales by Companies, (K Units), 2017-2022
Table 6. Global Bioengineered Protein Drugs Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Bioengineered Protein Drugs Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Bioengineered Protein Drugs Product Type
Table 9. List of Global Tier 1 Bioengineered Protein Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Bioengineered Protein Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Bioengineered Protein Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Bioengineered Protein Drugs Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Bioengineered Protein Drugs Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Bioengineered Protein Drugs Sales (K Units), 2017-2022
Table 15. By Type - Global Bioengineered Protein Drugs Sales (K Units), 2023-2028
Table 16. By Application – Global Bioengineered Protein Drugs Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Bioengineered Protein Drugs Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Bioengineered Protein Drugs Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Bioengineered Protein Drugs Sales (K Units), 2017-2022
Table 20. By Application - Global Bioengineered Protein Drugs Sales (K Units), 2023-2028
Table 21. By Region – Global Bioengineered Protein Drugs Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Bioengineered Protein Drugs Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Bioengineered Protein Drugs Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Bioengineered Protein Drugs Sales (K Units), 2017-2022
Table 25. By Region - Global Bioengineered Protein Drugs Sales (K Units), 2023-2028
Table 26. By Country - North America Bioengineered Protein Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Bioengineered Protein Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Bioengineered Protein Drugs Sales, (K Units), 2017-2022
Table 29. By Country - North America Bioengineered Protein Drugs Sales, (K Units), 2023-2028
Table 30. By Country - Europe Bioengineered Protein Drugs Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Bioengineered Protein Drugs Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Bioengineered Protein Drugs Sales, (K Units), 2017-2022
Table 33. By Country - Europe Bioengineered Protein Drugs Sales, (K Units), 2023-2028
Table 34. By Region - Asia Bioengineered Protein Drugs Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Bioengineered Protein Drugs Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Bioengineered Protein Drugs Sales, (K Units), 2017-2022
Table 37. By Region - Asia Bioengineered Protein Drugs Sales, (K Units), 2023-2028
Table 38. By Country - South America Bioengineered Protein Drugs Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Bioengineered Protein Drugs Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Bioengineered Protein Drugs Sales, (K Units), 2017-2022
Table 41. By Country - South America Bioengineered Protein Drugs Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Bioengineered Protein Drugs Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Bioengineered Protein Drugs Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Bioengineered Protein Drugs Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Bioengineered Protein Drugs Sales, (K Units), 2023-2028
Table 46. Dr.Reddy’s Corporate Summary
Table 47. Dr.Reddy’s Bioengineered Protein Drugs Product Offerings
Table 48. Dr.Reddy’s Bioengineered Protein Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Eli Lilly Corporate Summary
Table 50. Eli Lilly Bioengineered Protein Drugs Product Offerings
Table 51. Eli Lilly Bioengineered Protein Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Merck Corporate Summary
Table 53. Merck Bioengineered Protein Drugs Product Offerings
Table 54. Merck Bioengineered Protein Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Reliance Life Sciences Corporate Summary
Table 56. Reliance Life Sciences Bioengineered Protein Drugs Product Offerings
Table 57. Reliance Life Sciences Bioengineered Protein Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. Panacea Biotech Corporate Summary
Table 59. Panacea Biotech Bioengineered Protein Drugs Product Offerings
Table 60. Panacea Biotech Bioengineered Protein Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. Novartis Corporate Summary
Table 62. Novartis Bioengineered Protein Drugs Product Offerings
Table 63. Novartis Bioengineered Protein Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. Fresenius Corporate Summary
Table 65. Fresenius Bioengineered Protein Drugs Product Offerings
Table 66. Fresenius Bioengineered Protein Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. Sanofi Corporate Summary
Table 68. Sanofi Bioengineered Protein Drugs Product Offerings
Table 69. Sanofi Bioengineered Protein Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 70. ProBioGen Corporate Summary
Table 71. ProBioGen Bioengineered Protein Drugs Product Offerings
Table 72. ProBioGen Bioengineered Protein Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 73. GlaxoSmithKline Corporate Summary
Table 74. GlaxoSmithKline Bioengineered Protein Drugs Product Offerings
Table 75. GlaxoSmithKline Bioengineered Protein Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 76. Roche Corporate Summary
Table 77. Roche Bioengineered Protein Drugs Product Offerings
Table 78. Roche Bioengineered Protein Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 79. Amoytop Biotech Corporate Summary
Table 80. Amoytop Biotech Bioengineered Protein Drugs Product Offerings
Table 81. Amoytop Biotech Bioengineered Protein Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 82. Shanghai United Cell Biotechnology Corporate Summary
Table 83. Shanghai United Cell Biotechnology Bioengineered Protein Drugs Product Offerings
Table 84. Shanghai United Cell Biotechnology Bioengineered Protein Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 85. Hualan Bio Corporate Summary
Table 86. Hualan Bio Bioengineered Protein Drugs Product Offerings
Table 87. Hualan Bio Bioengineered Protein Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 88. Bioengineered Protein Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 89. Global Bioengineered Protein Drugs Capacity Market Share of Key Manufacturers, 2020-2022
Table 90. Global Bioengineered Protein Drugs Production by Region, 2017-2022 (K Units)
Table 91. Global Bioengineered Protein Drugs Production by Region, 2023-2028 (K Units)
Table 92. Bioengineered Protein Drugs Market Opportunities & Trends in Global Market
Table 93. Bioengineered Protein Drugs Market Drivers in Global Market
Table 94. Bioengineered Protein Drugs Market Restraints in Global Market
Table 95. Bioengineered Protein Drugs Raw Materials
Table 96. Bioengineered Protein Drugs Raw Materials Suppliers in Global Market
Table 97. Typical Bioengineered Protein Drugs Downstream
Table 98. Bioengineered Protein Drugs Downstream Clients in Global Market
Table 99. Bioengineered Protein Drugs Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Bioengineered Protein Drugs Segment by Type
Figure 2. Bioengineered Protein Drugs Segment by Application
Figure 3. Global Bioengineered Protein Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Bioengineered Protein Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Bioengineered Protein Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. Bioengineered Protein Drugs Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Bioengineered Protein Drugs Revenue in 2021
Figure 9. By Type - Global Bioengineered Protein Drugs Sales Market Share, 2017-2028
Figure 10. By Type - Global Bioengineered Protein Drugs Revenue Market Share, 2017-2028
Figure 11. By Type - Global Bioengineered Protein Drugs Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Bioengineered Protein Drugs Sales Market Share, 2017-2028
Figure 13. By Application - Global Bioengineered Protein Drugs Revenue Market Share, 2017-2028
Figure 14. By Application - Global Bioengineered Protein Drugs Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Bioengineered Protein Drugs Sales Market Share, 2017-2028
Figure 16. By Region - Global Bioengineered Protein Drugs Revenue Market Share, 2017-2028
Figure 17. By Country - North America Bioengineered Protein Drugs Revenue Market Share, 2017-2028
Figure 18. By Country - North America Bioengineered Protein Drugs Sales Market Share, 2017-2028
Figure 19. US Bioengineered Protein Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Bioengineered Protein Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Bioengineered Protein Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Bioengineered Protein Drugs Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Bioengineered Protein Drugs Sales Market Share, 2017-2028
Figure 24. Germany Bioengineered Protein Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. France Bioengineered Protein Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Bioengineered Protein Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Bioengineered Protein Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Bioengineered Protein Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Bioengineered Protein Drugs Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Bioengineered Protein Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Bioengineered Protein Drugs Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Bioengineered Protein Drugs Sales Market Share, 2017-2028
Figure 33. China Bioengineered Protein Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Bioengineered Protein Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Bioengineered Protein Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Bioengineered Protein Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. India Bioengineered Protein Drugs Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Bioengineered Protein Drugs Revenue Market Share, 2017-2028
Figure 39. By Country - South America Bioengineered Protein Drugs Sales Market Share, 2017-2028
Figure 40. Brazil Bioengineered Protein Drugs Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Bioengineered Protein Drugs Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Bioengineered Protein Drugs Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Bioengineered Protein Drugs Sales Market Share, 2017-2028
Figure 44. Turkey Bioengineered Protein Drugs Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Bioengineered Protein Drugs Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Bioengineered Protein Drugs Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Bioengineered Protein Drugs Revenue, (US$, Mn), 2017-2028
Figure 48. Global Bioengineered Protein Drugs Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Bioengineered Protein Drugs by Region, 2021 VS 2028
Figure 50. Bioengineered Protein Drugs Industry Value Chain
Figure 51. Marketing Channels